Home>Topics>>NPS Pharmaceuticals' CEO Discusses FDA Approval and Commercial launch of Gattex (Transcript)
NPS Pharmaceuticals' CEO Discusses FDA Approval and Commercial launch of Gattex (Transcript)
Healthcare Sector and Stocks Analysis from Seeking Alpha
Wed, 2 Jan 2013
NPS Pharmaceuticals, Inc. ( NPSP ) Discussion on FDA Approval of Gattex Call January 2, 2013 5:00 PM ET Executives Susan Mesco – Senior Director, IR and Corporate Communications Francois Nader – President and CEO Eric Pauwels – SVP and Chief Commercial Officer Analysts Salveen Richter – Canaccord ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.